Antibiotic Development Needs Economic Incentives
The antibiotic market is categorically different from that of other pharmaceuticals. Research and development of any drug is expensive, but antibiotics have comparatively low prices and sales volume.
As a result, the companies making them are going bankrupt, and many potentially lifesaving drugs end up falling into an antibiotic valley of death—dropping out of production before they can reach patients.
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!